Prostate Cancer - Results from #22340

The use of an active appearance model for automated prostate segmentation in magnetic resonance - Abstract October 8, 2013

Ten-year outcomes of sexual function after radical prostatectomy: Results of a prospective longitudinal study - Abstract October 8, 2013

Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: Identifying candidates for early salvage therapy - Abstract October 8, 2013

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer - Abstract October 8, 2013

Biochemical and objective response to abiraterone acetate withdrawal: Incidence and clinical relevance of a new scenario for castration-resistant prostate cancer - Abstract October 8, 2013

Co-existent Paget's disease of the bone, prostate carcinoma skeletal metastases and fracture on skeletal scintigraphy-lessons to be learned - Abstract October 8, 2013

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer - Abstract October 8, 2013

Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era - Abstract October 8, 2013

3D prostate histology reconstruction: An evaluation of image-based and fiducial-based algorithms - Abstract October 8, 2013

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: Interim analysis of acute toxicity and quality of life in 124 patients - Abstract October 8, 2013

Complementary and alternative medicine (CAM) in prostate and bladder cancer - Abstract October 8, 2013

Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells - Abstract October 7, 2013

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer - Abstract October 7, 2013

Androgens and prostate cancer; pathogenesis and deprivation therapy - Abstract October 7, 2013

Epigenetic susceptibility factors for prostate cancer with aging - Abstract October 7, 2013

Prostate cancer detection and diagnosis: The role of MR and its comparison with other diagnostic modalities - A radiologist's perspective - Abstract October 7, 2013

Results of radical prostatectomy in newly diagnosed prostate cancer: Long-term survival rates in locally advanced and high-risk cancers - Abstract October 7, 2013

Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer - Abstract October 7, 2013

Evaluation of image-guidance strategies for prostate cancer - Abstract October 7, 2013

11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: Preliminary results of tolerability and acute toxicity - Abstract October 7, 2013

Page 1118 of 1447